• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Racial differences exist in emphysema prevalence in adults with normal spirometry findings

byDavid XiangandKiera Liblik
August 10, 2022
in Chronic Disease, Public Health
Reading Time: 3 mins read
Non-invasive ventilation linked with lower mortality in COPD exacerbations
Share on FacebookShare on TwitterShare on LinkedIn

1. Black men are more likely than White men to have emphysema with normal spirometry findings.

2. Black women had a slightly higher prevalence of emphysema than White women.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Chronic obstructive pulmonary disease (COPD) is defined as airflow limitation on spirometry with an FEV1/FVC ratio less than 0.7 or less than the lower limit of normal. However, patients with preserved lung function can still have respiratory symptoms, exacerbations, and accelerated lung decline similar to that observed in COPD. It is also understood that racial disparities exist in COPD outcomes and rates of COPD underdiagnosis. Therefore, there is a gap in knowledge as to understanding the prevalence of emphysema on CT among those with normal spirometry findings, and whether differences exist in the prevalence of emphysema among Black and White adults. Overall, this study found that emphysema is commonly present before spirometry findings become abnormal. Further, the prevalence of emphysema is higher among Black men than White men. This study was limited by the inability to examine CT imaging and spirometry at the same time. Imaging was obtained five years before spirometry, and emphysema is a progressive and irreversible disease, so this may have led to an overall underestimation of the prevalence of emphysema. Nevertheless, these study’s findings are significant, as they demonstrate that emphysema can present before finding abnormal spirometry results and that these rates of emphysema may be impacted by race.

Click to read the study in AIM

Relevant Reading: Association Between Emphysema-like Lung on Cardiac Computed Tomography and Mortality in Persons Without Airflow Obstruction

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

In-Depth [observational study]: The CARDIA (Coronary Artery Risk Development in Young Adults) study is a multicenter, population-based, longitudinal cohort study that enrolled 5,115 Black and White participants aged 18 to 30 years. Spirometry and clinical data were taken from 2015 to 2016 and CT scans were obtained from 2010 to 2011. The primary outcome measure was the prevalence of emphysema among participants with various measures of normal spirometry results, including an FEV1/FVC ratio greater than or equal to 0.7 or greater than or equal to the lower limit of normal, stratified by sex and self-reported race. Outcomes in the primary analysis were assessed via sex-specific multivariate logistic regression to calculate the adjusted prevalence of emphysema as well as age, smoking status, and pack-years of smoking. Based on the primary analysis, among patients who had emphysema despite normal spirometry results with a race-specific FEV1 between 80 and 99% predicted. Emphysema prevalence was 3.9 fold (95% Confidence Interval [CI], 2.1 to 7.1 fold) higher among Black men than White men and 1.9 fold higher (95% CI, 1.0 to 3.8 told) higher among Black women than White women. In patients with FEV1 between 100% and 120% of predicted, Black men had a 6.4 fold (95% CI, 2.2 to 18.7 fold) higher prevalence of prevalence than White men. Black and White women had a similar prevalence of emphysema (2.6% and 2.0%). Overall, this study demonstrates that emphysema is present even when there are normal spirometry findings and that the prevalence of emphysema is higher among Black men than White men.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseasecopdemphysemaPFTpublic healthpulmonary function testpulmonologyracerespirologyspirometry
Previous Post

#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers

Next Post

MRI effective for the assessment of acute appendicitis in pregnancy [Classics Series]

RelatedReports

A senior woman looks thoughtfully at a balance scale with a stethoscope and a heart illustration, symbolizing the assessment of cardiovascular risk and treatment decisions.
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

A landmark court ruling was associated with increased travel across state borders for abortion care

August 28, 2026
Natural language processing may automate data extraction from radiologic reports
Chronic Disease

Many patients using patient portals may not fully understand results of laboratory testing

August 26, 2026
Next Post
ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

MRI effective for the assessment of acute appendicitis in pregnancy [Classics Series]

Parental debt influences child socioemotional well-being

Type of compensation model influences gender pay gap in primary care

2 Minute Medicine Rewind October 12 – 19, 2014

Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.